Opexa Therapeutics (OPXA) to Present at the Merriman Curhan Ford & Co. 6th Annual Investor Summit 2009 on November 10, 2009
11/5/2009 9:28:59 AM
More...
|
Opexa Therapeutics (OPXA) Reports Third Quarter 2009 Financial Results and Corporate Update
11/4/2009 9:01:59 AM
More...
|
Opexa Therapeutics (OPXA) Triggers Milestone Payment From Novartis AG Under Recently Announced Stem Cell Agreement
9/23/2009 10:07:20 AM
More...
|
Opexa Therapeutics (OPXA) to Present at the Wall Street Analyst Forum 20th Annual Analyst Conference
9/22/2009 9:03:01 AM
More...
|
Opexa Therapeutics (OPXA) to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009
9/8/2009 10:15:13 AM
More...
|
Opexa Therapeutics (OPXA)'s Stem Cell Technology Acquired by Novartis Corporation (NVS) (JOBS) in $50 Million Deal
8/7/2009 6:26:17 AM
More...
|
Opexa Therapeutics (OPXA) Receives Favorable NASDAQ Determination
6/9/2009 9:15:05 AM
More...
|
Opexa Therapeutics (OPXA) Reports First Quarter 2009 Financial Results and Closes Private Financing
5/15/2009 10:49:19 AM
More...
|
Opexa Therapeutics (OPXA) Publication of Tovaxin(R) Clinical Data in Journal of Clinical Immunology
4/24/2009 9:27:25 AM
More...
|
Opexa Therapeutics (OPXA) Closes First Tranche of Additional Financing
4/16/2009 9:15:32 AM
More...
|
|